Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation
Status:
Terminated
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to show that PET-MR imaging can be used for obtaining a
pharmacodynamic profile of drugs. By using the 5-HT1B receptor as target we also aim to find
effect areas and sizes of the 5-HT1B receptor agonist sumatriptan.